Prevalence of hyperuricemia and its related risk factors in healthy adults from Northern and Northeastern Chinese provinces

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Qiu, Ling ^a   Cheng, Xin Qi ^a   Wu, Jie ^a   Liu, Jun Ting ^b   Xu, Tao ^c   Ding, Hai Tao ^d   Liu, Yan Hong ^e   Ge, Zeng Mei ^a   Wang, Ya Jing ^a   Han, Hui Juan ^a   Liu, Jing ^a   Zhu, Guang Jin ^c  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b CAPITAL INSTITUTE OF PEDIATRICS   (China)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^d Inner Mongolian People's Hospital   (China)

^e HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Hyperuricemia; Prevalence; Risk factors

Indexed keywords

ADOLESCENT; ADULT; AGED; CHINA; FEMALE; HUMAN; HYPERURICEMIA; MALE; MIDDLE AGED; PREVALENCE; RISK FACTOR; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHINA; FEMALE; HUMANS; HYPERURICEMIA; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84880182506     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-664     Document Type: Article

References (28)

1. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. Lin KC, Lin HY, Chou P, J Rheumatol 2000 27 6 1501 1505 10852278 (Pubitemid 30354052)
2. Hyperuricemia and insulin resistance. Vuorinen-Markkola H, Yki-Jarvinen H, J Clin Endocrinol Metab 1994 78 1 25 29 10.1210/jc.78.1.25 8288709 (Pubitemid 24026741)
3. Relevance of uric acid in progression of type 2 diabetes mellitus. Causevic A, Semiz S, Macic Dzankovic A, Cico B, Dujic T, Malenica M, Bego T, Bosn J Basic Med Sci 2010 10 1 54 59 20192932
4. Uric acid and the development of hypertension. Hwu CM, Lin KH, Med Sci Monit 2010 16 10 A224 RA230 20885365
5. Uric acid: a marker of increased cardiovascular risk. Gagliardi AC, Miname MH, Santos RD, Atherosclerosis 2009 202 1 11 17 10.1016/j. atherosclerosis.2008.05.022 18585721
6. Uric acid as a factor in the metabolic syndrome. Borges RL, Ribeiro AB, Zanella MT, Batista MC, Curr Hypertens Rep 2010 12 2 113 119 10.1007/s11906-010-0098-2 20424936
7. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Choi HK, Ford ES, Am J Med 2007 120 5 442 447 10.1016/j.amjmed.2006.06.040 17466656 (Pubitemid 46656248)
8. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R, J Rheumatol 2004 31 8 1582 1587 15290739 (Pubitemid 39006641)
9. The role of hyperuricemia in vascular disorders. Edwards NL, Curr Opin Rheumatol 2009 21 2 132 137 10.1097/BOR.0b013e3283257b96 19339923
10. Prevalence of hyperuricemia and its relationship with metabolic syndrome in Thai adults receiving annual health exams. Lohsoonthorn V, Dhanamun B, Williams MA, Arch Med Res 2006 37 7 883 889 10.1016/j.arcmed.2006.03.008 16971230 (Pubitemid 44333145)
11. Prevalence of hyperuricemia in Bangkok population. Uaratanawong S, Suraamornkul S, Angkeaw S, Uaratanawong R, Clin Rheumatol 2011 30 7 887 893 10.1007/s10067-011-1699-0 21302126
12. Prevalence of hyperuricemia and its association with antihypertensive treatment in hypertensive patients in Taiwan. Lin CS, Lee WL, Hung YJ, Lee DY, Chen KF, Chi WC, Chang SC, Int J Cardiol 2012 156 1 41 46 10.1016/j.ijcard.2010. 10.033 21095025
13. The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. Nan H, Qiao Q, Dong Y, Gao W, Tang B, Qian R, Tuomilehto J, J Rheumatol 2006 33 7 1346 1350 16821269 (Pubitemid 44025149)
14. Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. Miao Z, Li C, Chen Y, Zhao S, Wang Y, Wang Z, Chen X, Xu F, Wang F, Sun R, et al. J Rheumatol 2008 35 9 1859 1864 18634142
15. The prevalence of hyperuricemia in China: a meta-analysis. Liu B, Wang T, Zhao HN, Yue WW, Yu HP, Liu CX, Yin J, Jia RY, Nie HW, BMC Publ Health 2011 11 832 10.1186/1471-2458-11-832
16. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G, Ann Intern Med 2003 139 2 137 147 10.7326/0003-4819-139-2-200307150-00013 12859163
17. Study on the prevalence of hyperuricemia and its association with the various metabolic disorders in Han and Korean nationality. Li MH, Xiong YH, Fang JN, Modern Preventive Medicine 2010 37 13 2472 2475
18. Analysis on prevalence and influence factors of hyperuricemia among residents in Qingdao. Tian XC, Pang ZC, Bao GC, Chin J Publ ic Health 2008 24 3 360 362
19. Epidemiological study on hyperuricemia and gout in the coastal area of Qingdao city. Yao ZL, Jia SJ, Liu H, Wan XQ, Ding ZG, Chin J Rheumatol 2007 49 11 622 625
20. An epidemiologic study on hyperuricaemia and gout in residents of coastal areas of Haiyang City in Shandong. Zhang XS, Yu WG, Yu LX, Zhang LY, Yu Y, Chin J Gen Pract 2006 5 4 216 219
21. Epidemiological survey of hyperuricemia and gout in coastal areas of Shandong Province. Miao ZM, Zhao SH, Wang YG, Chin J Endocrinol Metab 2006 11 421 425
22. Analysis on prevalence and influence factors of hyperuricemia among residents in Sichuan. Chen XL, Zou YR, Li GS, Xiao YY, Wang L, Sichuan Med J 2008 29 9 1267 1269
23. The prevalence and risk factors of hyperuricaemia in Yan'an. Li SL, Yu JX, Lv SY, Zhang YL, Chin Prev Med 2010 11 8 763 765
24. Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. Lin KC, Lin HY, Chou P, J Rheumatol 2000 27 4 1045 1050 10782835 (Pubitemid 30389766)
25. Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men. Tsai EC, Boyko EJ, Leonetti DL, Fujimoto WY, Int J Obes Relat Metab Disord 2000 24 4 485 491 10.1038/sj.ijo.0801183 10805506 (Pubitemid 30198102)
26. Hyperuricemia, gout and the metabolic syndrome. Puig JG, Martinez MA, Curr Opin Rheumatol 2008 20 187 191 10.1097/BOR.0b013e3282f4b1ed 18349749 (Pubitemid 351339891)
27. Metabolic syndrome characteristics in gout patients. Fraile JM, Torres RJ, de Miguel ME, Martinez P, Lundelin KJ, Vazquez JJ, Nucleosides Nucleotides Nucleic Acids 2010 29 325 329 10.1080/15257771003738709 20544515
28. Pathogenesis of gout. Choi HK, Mount DB, Reginato AM, Ann Intern Med 2005 143 499 516 10.7326/0003-4819-143-7-200510040-00009 16204163 (Pubitemid 41379398) Technology